NCT05614765View on ClinicalTrials.gov

Evaluation of Dyslipidemia Management After Statin and Ezetimibe Complex Treatment

Active, not recruitingOBSERVATIONAL
Enrollment

18,000

Participants

Timeline

Start Date

July 8, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2025

Conditions
Dyslipidemias
Interventions
DRUG

Statin+Ezetimibe compound

Crezet Tablet, Litorvazet Tablet

Trial Locations (1)

Unknown

Korea University Guro Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

NCT05614765 - Evaluation of Dyslipidemia Management After Statin and Ezetimibe Complex Treatment | Biotech Hunter | Biotech Hunter